Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.
作者信息
Nickel J Curtis, Aaron Lorne, Barkin Jack, Elterman Dean, Nachabé Mahmoud, Zorn Kevin C
机构信息
Department of Urology, Queen's University, Kingston, ON, Canada.
Service d'Urologie and Centre de la Prostate, Longueuil, QC, Canada.
出版信息
Can Urol Assoc J. 2018 Oct;12(10):303-312. doi: 10.5489/cuaj.5616.
Abstract
摘要
相似文献
1
Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.加拿大泌尿外科协会男性下尿路症状/良性前列腺增生（MLUTS/BPH）指南：2018年更新版
Can Urol Assoc J. 2018 Oct;12(10):303-312. doi: 10.5489/cuaj.5616.
2
UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia.更新 - 加拿大泌尿外科协会指南：男性下尿路症状/良性前列腺增生
Can Urol Assoc J. 2022 Aug;16(8):245-256. doi: 10.5489/cuaj.7906.
3
Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.新加坡泌尿外科协会男性下尿路症状/良性前列腺增生临床指南
Singapore Med J. 2017 Aug;58(8):473-480. doi: 10.11622/smedj.2017082.
4
5
Cross-cultural adaptation of the international consultation incontinence questionnaire male lower urinary tract symptoms-long form (ICIQ-MLUTS-LF) in Persian.国际咨询性尿失禁问卷男性下尿路症状长表（ICIQ-MLUTS-LF）的波斯语跨文化适应性研究
Neurourol Urodyn. 2017 Jun;36(5):1288-1291. doi: 10.1002/nau.23113. Epub 2016 Nov 4.
6
[Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].[全科医生管理良性前列腺增生相关下尿路症状指南]
Prog Urol. 2015 Jun;25(7):404-12. doi: 10.1016/j.purol.2015.02.008. Epub 2015 Apr 2.
7
Korean clinical practice guideline for benign prostatic hyperplasia.韩国良性前列腺增生临床实践指南。
Investig Clin Urol. 2016 Jan;57(1):30-44. doi: 10.4111/icu.2016.57.1.30. Epub 2016 Jan 11.
8
The rising worldwide impact of benign prostatic hyperplasia.良性前列腺增生症在全球范围内的影响日益增加。
BJU Int. 2021 Jun;127(6):722-728. doi: 10.1111/bju.15286. Epub 2020 Nov 21.
9
Canadian guidelines for the management of benign prostatic hyperplasia.加拿大良性前列腺增生管理指南。
Can J Urol. 2005 Jun;12(3):2677-83.
10
[Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].[良性前列腺增生的诊断检查：2023年德国S2e指南第1部分]
Urologie. 2023 Aug;62(8):805-817. doi: 10.1007/s00120-023-02142-0. Epub 2023 Jul 4.
引用本文的文献
1
Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a retrospective cohort study.既往接受前列腺尿道悬吊术治疗良性前列腺增生继发下尿路症状后水刀汽化术的疗效、可行性及安全性：一项回顾性队列研究
World J Urol. 2025 Sep 3;43(1):535. doi: 10.1007/s00345-025-05897-7.
2
A comparative analysis of the outcomes of Rezūm therapy based on prostate size: a four-year retrospective analysis.基于前列腺大小的Rezūm疗法疗效比较分析：一项四年回顾性分析。
World J Urol. 2025 Jul 17;43(1):443. doi: 10.1007/s00345-025-05793-0.
3
Comparison of outcome for holmium laser enucleation prostate and Rezum system in benign prostate hyperplasia: a matched pair analysis.钬激光前列腺剜除术与Rezum系统治疗良性前列腺增生症的疗效比较：配对分析
World J Urol. 2025 Apr 22;43(1):242. doi: 10.1007/s00345-025-05644-y.
4
Risks and side effects in the medical management of benign prostatic hyperplasia.良性前列腺增生症药物治疗中的风险与副作用
Prostate Int. 2024 Jun;12(2):57-64. doi: 10.1016/j.prnil.2023.11.004. Epub 2023 Dec 2.
5
Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes.水蒸气热疗法治疗前列腺体积较大的良性前列腺增生所致下尿路症状的前瞻性试验：6个月和12个月结果
Eur Urol Open Sci. 2023 Nov 8;58:64-72. doi: 10.1016/j.euros.2023.10.006. eCollection 2023 Dec.
6
Benign prostatic hyperplasia surgical re-treatment after prostatic urethral lift A narrative review.前列腺尿道悬吊术后良性前列腺增生的手术再治疗：一项叙述性综述
Can Urol Assoc J. 2023 Oct;17(10):353-359. doi: 10.5489/cuaj.8334.
7
Prophylactic A-Blockers for Radiotherapy-Induced Lower Urinary Tract Symptoms in Men with Prostate Cancer: A Phase III Randomized Trial.预防性使用α受体阻滞剂治疗前列腺癌男性放疗所致下尿路症状：一项III期随机试验
Cancers (Basel). 2023 Jun 30;15(13):3444. doi: 10.3390/cancers15133444.
8
Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database.绿光180瓦光选择性汽化术治疗大体积（≥80立方厘米）前列腺患者的功能结局：对全球绿光治疗组（GGG）数据库中3000多名男性的分析
World J Urol. 2023 Feb;41(2):529-536. doi: 10.1007/s00345-022-04260-4. Epub 2022 Dec 19.
9
Canadian Urological Association best practice report: Diagnosis and management of nocturia.加拿大泌尿外科协会最佳实践报告：夜尿症的诊断与管理
Can Urol Assoc J. 2022 Jul;16(7):E336-E349. doi: 10.5489/cuaj.7970.
10
Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.药物治疗与微创治疗作为中重度良性前列腺增生初始治疗方法的成本效益研究
Prostate Cancer Prostatic Dis. 2023 Mar;26(1):113-118. doi: 10.1038/s41391-022-00561-2. Epub 2022 Jun 10.
本文引用的文献
1
Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.双极与单极经尿道前列腺切除术治疗良性前列腺梗阻继发的下尿路症状
Cochrane Database Syst Rev. 2019 Dec 3;12(12):CD009629. doi: 10.1002/14651858.CD009629.pub4.
2
Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes.使用180瓦XPS绿激光对前列腺进行光选择性汽化：五年的安全性、有效性及功能结果经验。
Can Urol Assoc J. 2018 Jul;12(7):E318-E324. doi: 10.5489/cuaj.4895. Epub 2018 Mar 19.
3
Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.加拿大泌尿外科协会关于前列腺癌筛查和早期诊断的建议。
Can Urol Assoc J. 2017 Oct;11(10):298-309. doi: 10.5489/cuaj.4888.
4
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.水：良性前列腺增生症经尿道前列腺电切术与 Aquablation 治疗的双盲、随机、对照试验。
J Urol. 2018 May;199(5):1252-1261. doi: 10.1016/j.juro.2017.12.065. Epub 2018 Jan 31.
5
Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study.坦索罗辛与西洛多辛在计划进行无导尿管试验的良性前列腺增生继发急性尿潴留患者管理中的比较。一项前瞻性随机研究。
Cent European J Urol. 2017;70(3):259-263. doi: 10.5173/ceju.2017.1313. Epub 2017 Jun 29.
6
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.前列腺尿道L.I.F.T.前瞻性随机对照研究的五年结果。
Can J Urol. 2017 Jun;24(3):8802-8813.
7
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.每日服用50毫克米拉贝隆治疗男性膀胱过度活动症患者的疗效与安全性：五项III期研究的批判性分析
Ther Adv Urol. 2017 May 10;9(6):137-154. doi: 10.1177/1756287217702797. eCollection 2017 Dec.
8
Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results.经水囊前列腺切除术治疗有症状的良性前列腺增生：1年结果
J Urol. 2017 Jun;197(6):1565-1572. doi: 10.1016/j.juro.2017.01.056. Epub 2017 Jan 20.
9
Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.对流热疗法：针对良性前列腺增生所致下尿路症状的随机对照及前瞻性交叉研究的2年持久结果
J Urol. 2017 Jun;197(6):1507-1516. doi: 10.1016/j.juro.2016.12.045. Epub 2016 Dec 18.
10
Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression.前列腺动脉栓塞术的疗效和安全性：系统评价与荟萃分析及荟萃回归。
J Urol. 2017 Feb;197(2):465-479. doi: 10.1016/j.juro.2016.08.100. Epub 2016 Aug 31.
Zotero 插件